NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1042230125

Registered date:09/01/2024

Evaluation of the Accuracy of SmartRobin@AI

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedAtrial fibrillation
Date of first enrollment09/01/2024
Target sample size100
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDiagnosis rate, sensitivity, specificity of AF
Secondary OutcomeBackground Factors in SmartRobin AI Positive Cases (including False Positives): Hypertension Complications of Heart Failure Advanced Age/75 years or older Diabetes Stroke Gender Background Factors in SmartRobin AI True Positive Cases: Hypertension Complications of Heart Failure Advanced Age/75 years or older Diabetes Stroke Gender

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
Gender
Include criteriaPatients who underwent electrocardiogram examinations at our clinic from January 1, 2023, to August 31, 2023, and whose electrocardiographic waveforms were analyzed using the SmartRobin AI series.
Exclude criteriaNone

Related Information

Contact

Public contact
Name Mineki Takechi
Address 1-25-5 Higashi-Azabu, Minato-ku Tokyo Japan 106-0044
Telephone +81-3-6821-0390
E-mail contact-ci-info@cardio-i.com
Affiliation Cardio Intelligence Co., Ltd.
Scientific contact
Name Hiroyuki Osanai
Address 160 Nishi-Oiwake-cho, Seto City Aichi Japan 489-0065
Telephone +81-561825101
E-mail osanai@tosei.or.jp
Affiliation Tosei General Hospital